王洪涛;吕莹;李梦琪;刘卓刚;

• 1:中国医科大学附属盛京医院第一血液内科

摘要(Abstract)：

异基因造血干细胞移植(allogeneic hemopoietic stem cell transplantation,allo-HSCT)是白血病等血液系统疾病有效甚至唯一的根治手段,但移植物抗宿主病(graft versus host disease,GVHD)严重影响患者预后,是移植相关死亡的主要原因之一。新陈代谢是细胞最常见的特点,在免疫应答对T细胞的活化和分化等功能中具有重要作用。初始T细胞是主要介导GVHD的免疫细胞,其可以通过特异性的代谢过程获得相应的免疫功能。巨噬细胞、树突状细胞等固有免疫细胞的增殖和分化也需要通过代谢进行调节。Allo-HSCT后,以代谢途径作为靶点,抑制与GVHD相关的初始T细胞、保留移植物抗白血病相关的记忆性T细胞,可能对提高allo-HSCT的疗效、降低GVHD的发生率具有重要作用和意义。因此,深入研究和探讨代谢在移植中的意义及其机制并寻找可能的特异性治疗靶点至关重要。本文就GVHD代谢相关发病机制和研究进展做一综述。

关键词(KeyWords)： 异基因造血干细胞移植;移植物抗宿主病;代谢;T细胞

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金青年项目(81600115)

作者(Authors): 王洪涛;吕莹;李梦琪;刘卓刚;

参考文献(References)：

• [1]Saad A,Lamb LS.Ex vivo T-cell depletion in allogeneic hemat opoietic stem cell transplant:past,present and future[J].Bone Marrow Transplant,2017,52(9):1241-1248.
• [2]Chang YJ,Huang XJ.Haploidentical stem cell transplantation:anti-thymocyte globulin-based experience[J].Semin Hematol,2016,53(2):82-89.
• [3]Negrin RS.Graft-versus-host disease versus graft-versusleukemia[J].Hematology Am Soc Hematol Educ Program,2015,2015:225-230.
• [4]Blazar BR,Murphy WJ,Abedi M.Advances in graft-versushost disease biology and therapy[J].Nat Rev Immunol,2012,12(6):443-458.
• [5]Huang W,Chao NJ.Memory T cells:A helpful guard for alloge neic hematopoietic stem cell transplantation without cau sing graft-versus-host disease[J].Hematol Oncol Stem Cell Ther,2017,10(4):211-219.
• [6]Almeida L,Lochner M,Berod L,et al.Metabolic pathways in T cell activation and lineage differentiation[J].Semin Immunol,2016,28(5):514-524.
• [7]Buck MD,O'Sullivan D,Pearce EL.T cell metabolism drives immunity[J].J Exp Med,2015,212(9):1345-1360.
• [8]Byersdorfer CA,Tkachev V,Opipari AW,et al.Effector T cells require fatty acid metabolism during murine graft-versus-host disease[J].Blood,2013,122(18):3230-3237.
• [9]Zhang Y,Shlomchik WD,Joe G,et al.APCs in the liver and spleen recruit activated allogeneic CD8+T cells to elicit hepatic graft-versus-host disease[J].J Immunol,2002,169(12):7111-7118.
• [10]Oberbarnscheidt MH,Zeng Q,Li Q,et al.Non-self recognition by monocytes initiates allograft rejection[J].J Clin Invest,2014,124(8):3579-3589.
• [11]Mosaad YM.Immunology of hematopoietic stem cell transplant[J].Immunol Invest,2014,43(8):858-887.
• [12]O'Neill LA,Pearce EJ.Immunometabolism governs dendritic cell and macrophage function[J].J Exp Med,2016,213(1):15-23.
• [13]Vander Heiden MG,Cantley LC,Thompson CB.Understanding the Warburg effect:the metabolic requirements of cell proliferation[J].Science,2009,324(5930):1029-1033.
• [14]Herbel C,Patsoukis N,Bardhan K,et al.Clinical significance of T cell metabolic reprogramming in cancer[J].Clin Transl Med,2016,5(1):29.
• [15]Cairns RA,Harris IS,Mak TW.Regulation of cancer cell metabolism[J].Nat Rev Cancer,2011,11(2):85-95.
• [16]Chang CH,Curtis JD,Maggi LB Jr,et al.Posttranscriptional control of T cell effector function by aerobic glycolysis[J].Cell,2013,153(6):1239-1251.
• [17]Wahl DR,Petersen B,Warner R,et al.Characterization of the metabolic phenotype of chronically activated lymphocytes[J].Lupus,2010,19(13):1492-1501.
• [18]Cham CM,Gajewski TF.Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+effector T cells[J].J Immunol,2005,174(8):4670-4677.
• [19]O'Sullivan D,van der Windt GJ,Huang SC,et al.Memory CD8(+)T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development[J].Immunity,2014,41(1):75-88.
• [20]van der Windt GJ,Everts B,Chang CH,et al.Mitochondrial respiratory capacity is a critical regulator of CD8+T cell memory development[J].Immunity,2012,36(1):68-78.
• [21]Kuhnke A,Burmester GR,Krauss S,et al.Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocorticoid treatment[J].Ann Rheum Dis,2003,62(2):133-139.
• [22]Michalek RD,Gerriets VA,Jacobs SR,et al.Cutting edge:distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+T cell subsets[J].JImmunol,2011,186(6):3299-3303.
• [23]Powell JD,Delgoffe GM.The mammalian target of rapamycin:linking T cell differentiation,function,and metabolism[J].Immunity,2010,33(3):301-311.
• [24]Düvel K,Yecies JL,Menon S,et al.Activation of a metabolic gene regulatory network downstream of m TOR complex 1[J].Mol Cell,2010,39(2):171-183.
• [25]Delgoffe GM,Kole TP,Zheng Y,et al.The m TOR kinase differentially regulates effector and regulatory T cell lineage commitment[J].Immunity,2009,30(6):832-844.
• [26]Blagih J,Coulombe F,Vincent EE,et al.The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo[J].Immunity,2015,42(1):41-54.
• [27]Rolf J,Zarrouk M,Finlay DK,et al.AMPKα1:a glucose sensor that controls CD8 T-cell memory[J].Eur J Immunol,2013,43(4):889-896.
• [28]Mac Iver NJ,Blagih J,Saucillo DC,et al.The liver kinase B1is a central regulator of T cell development,activation,and metabolism[J].J Immunol,2011,187(8):4187-4198.
• [29]Berod L,Friedrich C,Nandan A,et al.De novo fatty acid synthesis controls the fate between regulatory T and T helper17 cells[J].Nat Med,2014,20(11):1327-1333.
• [30]Coghill JM,Sarantopoulos S,Moran TP,et al.Effector CD4+Tcells,the cytokines they generate,and GVHD:something old and something new[J].Blood,2011,117(12):3268-3276.
• [31]Zeng H,Cohen S,Guy C,et al.m TORC1 and m TORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper TCell Differentiation[J].Immunity,2016,45(3):540-554.
• [32]Battaglia M,Stabilini A,Roncarolo MG.Rapamycin selectively expands CD4+CD25+Fox P3+regulatory T cells[J].Blood,2005,105(12):4743-4748.
• [33]Lutz M,Mielke S.New perspectives on the use of m TORinhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease[J].Br J Clin Pharmacol,2016,82(5):1171-1179.
• [34]Chen YB,Efebera YA,Johnston L,et al.Increased Foxp3(+)Helios(+)Regulatory T Cells and Decreased Acute Graftversus-Host Disease after Allogeneic Bone Marrow Transplanta tion in Patients Receiving Sirolimus and RGI-2001,an Activator of Invariant Natural Killer T Cells[J].Biol Blood Marrow Transplant,2017,23(4):625-634.
• [35]Zeng H,Yang K,Cloer C,et al.m TORC1 couples immune signals and metabolic programming to establish T(reg)-cell function[J].Nature,2013,499(7459):485-490.
• [36]Zhang L,Tschumi BO,Lopez-Mejia IC,et al.Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner[J].Cell Rep,2016,14(5):1206-1217.
• [37]Shin HJ,Baker J,Leveson-Gower DB,et al.Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+regulatory T cells[J].Blood,2011,118(8):2342-2350.
• [38]Zeiser R,Leveson-Gower DB,Zambricki EA,et al.Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+regulatory T cells compared with conventional CD4+T cells[J].Blood,2008,111(1):453-462.
• [39]Mac Donald KP,Shlomchik WD,Reddy P.Biology of graftversus-host responses:recent insights[J].Biol Blood Marrow Transplant,2013,19(1 Suppl):S10-S14.
• [40]Nguyen HD,Chatterjee S,Haarberg KM,et al.Metabolic reprogramming of alloantigen-activated T cells after hematop oietic cell transplantation[J].J Clin Invest,2016,126(4):1337-1352.
• [41]Jacobs SR,Herman CE,Maciver NJ,et al.Glucose uptake is limiting in T cell activation and requires CD28-mediated Aktdependent and independent pathways[J].J Immunol,2008,180(7):4476-4486.
• [42]Sinclair LV,Rolf J,Emslie E,et al.Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation[J].Nat Immunol,2013,14(5):500-508.
• [43]Gatza E,Wahl DR,Opipari AW,et al.Manipulating the bioenergetics of alloreactive T cells causes their selective apopt osis and arrests graft-versus-host disease[J].Sci Transl Med,2011,3(67):67ra8.
• [44]Glick GD,Rossignol R,Lyssiotis CA,et al.Anaplerotic metabolism of alloreactive T cells provides a metabolic appr oach to treat graft-versus-host disease[J].J Pharmacol Exp Ther,2014,351(2):298-307.
• [45]Anderson BE,Mc Niff J,Yan J,et al.Memory CD4+T cells do not induce graft-versus-host disease[J].J Clin Invest,2003,112(1):101-108.
• [46]Edinger M,Hoffmann P,Ermann J,et al.CD4+CD25+regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation[J].Nat Med,2003,9(9):1144-1150.
• [47]Park MJ,Lee SY,Moon SJ,et al.Metformin attenuates graftversus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinaseautophagy for the balance between T helper 17 and Tregs[J].Transl Res,2016,173:115-130.
• [48]Belkaid Y,Hand TW.Role of the microbiota in immunity and inflammation[J].Cell,2014,157(1):121-141.
• [49]Chakraverty R,Sykes M.The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia[J].Blood,2007,110(1):9-17.
• [50]Tijaro-Ovalle NM,Karantanos T,Wang HT,et al.Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease[J].Front Immunol,2019,10:295.
• [51]Ogonek J,Kralj Juric M,Ghimire S,et al.Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation[J].Front Immunol,2016,7:507.
• [52]Alexander KA,Flynn R,Lineburg KE,et al.CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease[J].J Clin Invest,2014,124(10):4266-4280.
• [53]Everts B,Amiel E,Huang SC,et al.TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supp orts the anabolic demands of dendritic cell activation[J].Nat Immunol,2014,15(4):323-332.
• [54]Galván-Pe?a S,O'Neill LA.Metabolic reprograming in macrophage polarization[J].Front Immunol,2014,5:420.
• [55]Raud B,Roy DG,Divakaruni AS,et al.Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation[J].Cell Metab,2018,28(3):504-515.
• [56]Lu L,Chen Y,Zhu Y.The molecular basis of targeting PFKFB3as a therapeutic strategy against cancer[J].Oncotarget,2017,8(37):62793-62802.
• [57]Sukumar M,Liu J,Ji Y,et al.Inhibiting glycolytic metabolism enhances CD8+T cell memory and antitumor function[J].J Clin Invest,2013.123(10):4479-4488.
• [58]Herrero-Sánchez MC,Rodríguez-Serrano C,Almeida J,et al.Targeting of PI3K/AKT/m TOR pathway to inhibit T cell activation and prevent graft-versus-host disease develo pment[J].JHematol Oncol,2016,9(1):113.
• [59]Divakaruni AS,Hsieh WY,Minarrieta L,et al.Etomoxir Inhi bits Macrophage Polarization by Disrupting Co A Homeostasis[J].Cell Metab,2018,28(3):490-503
• [60]Zanin-Zhorov A,Ding Y,Kumari S,et al.Protein kinase C-theta mediates negative feedback on regulatory T cell function[J].Science,2010,328(5976):372-376.